Case-Crossover Analysis of Condom Use and Herpes Simplex Virus Type 2 Acquisition

被引:12
作者
Stanaway, Jeffrey D.
Wald, Anna [1 ,2 ,3 ,4 ]
Martin, Emily T. [5 ]
Gottlieb, Sami L. [6 ]
Magaret, Amalia S. [2 ,7 ]
机构
[1] Univ Washington, Harborview Med Ctr, Virol Res Clin, Dept Epidemiol, Seattle, WA 98104 USA
[2] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA
[3] Univ Washington, Dept Med, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA
[5] Wayne State Univ, Dept Pharm Practice, Detroit, MI USA
[6] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA
[7] Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA 98104 USA
基金
美国国家卫生研究院;
关键词
GENITAL HERPES; RISK-REDUCTION; ADOLESCENT POPULATION; INFECTION; TRANSMISSION; PREVENTION; HSV-2; WOMEN; SEROCONVERSION; PARTNERS;
D O I
10.1097/OLQ.0b013e318248aa8a
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although growing evidence suggests that condoms offer moderate protection against herpes simplex virus type 2 (HSV-2), inability to control for unknown or unmeasured confounders associated with sexual activity may reduce the accuracy of the estimates. The case-crossover design offers increased control of individual-level confounders, and was thus used with the aim of producing a more accurate estimate of the effect of condom use on HSV-2 acquisition. Methods: Data were pooled from 6 prospective studies that measured HSV-2 status at enrollment and over follow-up, and included periodic self-reported condom use and sexual activity. Sexual activity contemporaneous with acquisition was assigned to a case period; earlier sexual activity was assigned to a control period. Conditional logistic regression was used to assess differences in behavior during the case and control periods. Results: One hundred ninety-one eligible participants acquired HSV-2 during follow-up. This approach detected a 3.6% increase in the odds of HSV-2 acquisition with each unprotected act (odds ratio = 1.036; 95% confidence interval: 1.021-1.052), but no increase in the odds of acquisition associated with protected acts (odds ratio = 1.008; 95% confidence interval: 0.987-1.030). Conclusions: This analysis suggests that condoms offer significant protection against HSV-2 transmission.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 31 条
[1]  
[Anonymous], 2011, COND STDS FACT SHEET
[2]   Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection [J].
Ashley, RL ;
Eagleton, M ;
Pfeiffer, N .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1632-1633
[3]   Time course of Seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2 [J].
Ashley-Morrow, R ;
Krantz, E ;
Wald, A .
SEXUALLY TRANSMITTED DISEASES, 2003, 30 (04) :310-314
[4]   Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic [J].
Austin, H ;
Macaluso, M ;
Nahmias, A ;
Lee, FK ;
Kelaghan, J ;
Fleenor, M ;
Hook, EW .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (06) :329-334
[5]   RISK OF ACQUISITION OF GENITAL HERPES-SIMPLEX VIRUS TYPE-2 IN SEX PARTNERS OF PERSONS WITH GENITAL HERPES - A PROSPECTIVE COUPLE STUDY [J].
BRYSON, Y ;
DILLON, M ;
BERNSTEIN, DI ;
RADOLF, J ;
ZAKOWSKI, P ;
GARRATTY, E .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (04) :942-946
[6]   Herpes simplex virus type 2 in prisoners, New South Wales, Australia [J].
Butler, T ;
Donovan, B ;
Taylor, J ;
Cunningham, AL ;
Mindel, A ;
Levy, M ;
Kaldor, J .
INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (11) :743-747
[7]  
Casper Corey, 2002, Herpes, V9, P10
[8]   Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection - Two randomized controlled trials [J].
Corey, L ;
Langenberg, AGM ;
Ashley, R ;
Sekulovich, RE ;
Izu, AE ;
Douglas, JM ;
Handsfield, HH ;
Warren, T ;
Marr, L ;
Tyring, S ;
DiCarlo, R ;
Adimora, AA ;
Leone, P ;
Dekker, CL ;
Burke, RL ;
Leong, WP ;
Straus, SE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (04) :331-340
[9]   Once-daily valacyclovir to reduce the risk of transmission of genital herpes [J].
Corey, L ;
Wald, A ;
Patel, R ;
Sacks, SL ;
Tyring, SK ;
Warren, T ;
Douglas, JM ;
Paavonen, J ;
Morrow, RA ;
Beutner, KR ;
Stratchounsky, LS ;
Mertz, G ;
Keene, ON ;
Watson, HA ;
Tait, D ;
Vargas-Cortes, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :11-20
[10]   Evaluating AIDS prevention interventions using behavioral and biological outcome measures [J].
Fishbein, M ;
Pequegnat, W .
SEXUALLY TRANSMITTED DISEASES, 2000, 27 (02) :101-110